Global Technology Virtual Investor Conference
Logotype for TelyRx Holdings Inc

TelyRx Holdings (TELY) Global Technology Virtual Investor Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for TelyRx Holdings Inc

Global Technology Virtual Investor Conference summary

14 Jul, 2026

Market opportunity and business model

  • Addresses the inefficiencies in traditional pharmacy by offering over 450 everyday medications delivered quickly, without appointments, insurance, or lines.

  • Operates in the $98 billion cash-pay prescription market, growing at 40% annually, and avoids the regulatory hurdles faced by insurance-based competitors.

  • 100% cash-pay model enables full control over the value chain, from physician access to fulfillment, with no exposure to government reimbursement regulations.

  • Focuses on high-use, low-risk medications, ensuring broad reach and diversification across eight clinical categories.

  • Built for scalability with two strategically located pharmacies covering 97% of the U.S. population.

Financial performance and growth

  • Achieved $43 million in revenue last year, with over 50% compounded quarterly growth and 70% of revenue from repeat customers.

  • Q1 revenue reached $19.4 million, up 180% year-over-year and 35% quarter-over-quarter, with gross margins expanding to 55%.

  • Customer acquisition cost is $113, with a three-month payback period and average customer lifetime revenue of $524, which continues to grow.

  • Marketing spend yields a 3x return, and the company has transitioned to a fully in-house marketing team to drive further efficiency.

  • Gross profit margin improved from 37% to 54% in year two, with ongoing focus on margin expansion and disciplined growth.

Customer dynamics and retention

  • Nearly 50% of new customers become repeat buyers, with 20% making a second purchase within seven days and 60% within 30 days.

  • Average order value increases by 15% on follow-on transactions, and recurring customers drive the majority of revenue.

  • Investments in customer experience and technology aim to further increase retention and lifetime value.

  • Key KPIs tracked include lifetime revenue, customer acquisition cost, new vs. recurring customer mix, and prescription type distribution.

  • Plans to enhance customer engagement and platform features are underway, with more updates expected in upcoming quarters.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more